Moonwalk Biosciences
Pioneering novel therapeutics in adipose biology and tissue, driven by deep genetic and epigenetic insights
21 employees · est. 2022 · South San Francisco, United...
Precede Biosciences
Precede Bio is impacting precision medicine with a first-in-class 🩸 liquid biopsy platform
61 employees · est. 2021 · United States
Precede Biosciences is the older company (2022 vs 2021); Precede Biosciences is the larger of the two.
Side-by-Side Comparison
| Metric | Moonwalk Biosciences | Precede Biosciences |
|---|---|---|
| Founded | ||
| Founded | 2022 | 2021 older |
| Headquarters | ||
| Headquarters | South San Francisco, United States | United States |
| Employees | ||
| Employees | 21 | 61 larger |
| Industry | ||
| Industry | AI, Biopharma, Biotechnology | Not tracked yet |
| Funding Stage | ||
| Funding Stage | Series A | Series A |
| Total Funding | ||
| Total Funding | $57.00M | $120.50M |
| Funding Rounds | ||
| Funding Rounds | 2 | 2 |
| Services | ||
| Services | Development of therapeutics targeting obesity via adipose biology, Epigenetic and genetic research, Bioinformatics and data analytics for drug discovery, siRNA and RNA-based therapeutic platforms, Preclinical and translational biology research | Liquid biopsy platform development, Epigenomic analysis and profiling, Diagnostics for cancer and other diseases, Therapeutic target identification, Strategic partnerships with pharmaceutical companies, R&D in precision medicine |
| Target Customers | ||
| Target Customers | Pharmaceutical companies, Biotechnology firms, Research institutions, Healthcare providers focusing on obesity and metabolic disorders, Academic and clinical researchers | Pharmaceutical companies, Biotech firms, Oncology research institutions, Healthcare providers, Medical diagnostic labs |
| Taxonomy | ||
| Taxonomy | Adipose Biology, Therapeutics Development, Genetic Insights, Epigenetic Insights, Obesity Targets, Cardiometabolic Disease, Genomic Medicine, Precision Epigenetic Therapeutics, AI Prediction In Genomics, Epigenome Profiling, Target Identification, Therapeutic Candidates Pipeline, Discovery Platform, Novel Target Identification, Health And Disease Epigenomics | Precision Medicine, Liquid Biopsy, Transcriptional Biology, Chromatin Profiling, DNA Methylome, Genomic Medicine, Diagnostic Tests, Drug Development, Cancer Diagnosis, Minimally Invasive Diagnostics, Disease Biology, Machine Learning In Genomics, Artificial Intelligence In Healthcare, Oncology, Genomic Profiling |
| Website | ||
| Website | moonwalk.bio | precede.bio |
About Moonwalk Biosciences
Moonwalk Biosciences is making strides in the field of adipose biology and tissue through its highly specialized focus on novel therapeutics. Established in 2022, the company leans heavily on its proprietary discovery platform, which harnesses deep genetic and epigenetic insights to identify new the...
About Precede Biosciences
Precede Biosciences, founded in 2021, is at the forefront of precision medicine with its innovative first-in-class liquid biopsy platform. With headquarters in the United States, the company stands out for its commitment to enhance the medical community's understanding of disease-defining biology, o...
We will tell you when either one moves
BounceWatch watches Moonwalk Biosciences and Precede Biosciences for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Moonwalk Biosciences and Precede Biosciences — by email.
Frequently Asked Questions
Compare Moonwalk Biosciences with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Moonwalk Biosciences on 11 Mar 2026, and Precede Biosciences on 10 Apr 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
